Liminatus Pharma Inc. has entered into a settlement and release agreement with Alta Partners, LLC, resulting in the issuance of 350,000 shares of its common stock to Alta Partners in exchange for the cancellation of 1,000,000 warrants to purchase shares of common stock. The shares have a par value of $0.0001 each. No commission or remuneration was involved in this transaction.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-068670), on July 17, 2025, and is solely responsible for the information contained therein.